California Stem Cell, Inc. Announces Completion Of Phase I Cancer Stem Cell Clinical Trial For Hepatocellular Carcinoma
12/18/2013 9:54:21 AM
IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell, Inc. (CSC) announced today the successful completion of a Phase I clinical trial investigating the safety of a cancer stem cell-based therapy in patients with Stage IV hepatocellular carcinoma, a common form of advanced liver cancer. The trial, conducted in Shanghai, China in accordance with international standards, marks the second cancer type the Company has explored with its platform approach, the first being a Phase III treatment for melanoma in the United States.
Help employers find you! Check out all the jobs and post your resume.
comments powered by